ALX Offering Thursday, October 15, 2026 -0.40 Negative

Exercise material regarding pre-funded warrants issued by ALX Oncology

ALX Oncology issued pre-funded warrants to the holder, which allow the purchase common stock with an exercise price of $0.001, subject to specific SEC registration restrictions.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed